Savant Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74M | Buy |
53,489
+7,050
| +15% | +$493K | 0.02% | 371 |
|
|
2025
Q1 | $3.41M | Buy |
46,439
+614
| +1% | +$45.1K | 0.02% | 361 |
|
|
2024
Q4 | $3M | Buy |
45,825
+1,125
| +3% | +$73.7K | 0.02% | 328 |
|
|
2024
Q3 | $3.48M | Buy |
44,700
+4,127
| +10% | +$322K | 0.03% | 290 |
|
|
2024
Q2 | $3.16M | Sell |
40,573
-1,160
| -3% | -$90.5K | 0.03% | 273 |
|
|
2024
Q1 | $2.83M | Sell |
41,733
-317
| -0.8% | -$21.5K | 0.03% | 275 |
|
|
2023
Q4 | $2.83M | Sell |
42,050
-501
| -1% | -$33.7K | 0.04% | 230 |
|
|
2023
Q3 | $2.88M | Sell |
42,551
-508
| -1% | -$34.4K | 0.04% | 219 |
|
|
2023
Q2 | $3.08M | Buy |
43,059
+39,542
| +1,124% | +$2.83M | 0.05% | 213 |
|
|
2023
Q1 | $244K | Buy |
+3,517
| New | +$244K | ﹤0.01% | 642 |
|
|
2016
Q2 | – | Sell |
-7,814
| Closed | -$220K | – | 252 |
|
|
2016
Q1 | $220K | Buy |
+7,814
| New | +$220K | 0.07% | 206 |
|